{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:02:27Z","timestamp":1761919347280},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T00:00:00Z","timestamp":1280361600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10620-010-1352-9","type":"journal-article","created":{"date-parts":[[2010,7,28]],"date-time":"2010-07-28T08:37:38Z","timestamp":1280306258000},"page":"655-662","source":"Crossref","is-referenced-by-count":17,"title":["p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies"],"prefix":"10.1007","volume":"56","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,29]]},"reference":[{"key":"1352_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11894-008-0008-9","volume":"10","author":"DS Sandhu","year":"2008","unstructured":"Sandhu DS, Roberts LR. Diagnosis and management of cholangiocarcinoma. Curr Gastroenterol Rep. 2008;10:43\u201352.","journal-title":"Curr Gastroenterol Rep"},{"key":"1352_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2008.08.024","volume":"45","author":"CD Briggs","year":"2009","unstructured":"Briggs CD, Neal CP, Mann CD, et al. Prognostic molecular markers in cholangiocarcinoma: a systematic review. Eur J Cancer. 2009;45:33\u201347.","journal-title":"Eur J Cancer"},{"key":"1352_CR3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jnci\/djj234","volume":"98","author":"TM Welzel","year":"2006","unstructured":"Welzel TM, McGlynn KA, Hsing AW, et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98:873\u2013875.","journal-title":"J Natl Cancer Inst"},{"key":"1352_CR4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","volume":"48","author":"B Blechacz","year":"2008","unstructured":"Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308\u2013321.","journal-title":"Hepatology"},{"key":"1352_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(08)70027-5","volume":"9","author":"GK Bonney","year":"2008","unstructured":"Bonney GK, Craven RA, Prasad R, et al. Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol. 2008;9:149\u2013158.","journal-title":"Lancet Oncol"},{"key":"1352_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc2645","volume":"9","author":"A Walther","year":"2009","unstructured":"Walther A, Johnstone E, Swanton C, et al. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer. 2009;9:489\u2013499.","journal-title":"Nat Rev Cancer"},{"key":"1352_CR7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s004320000194","volume":"127","author":"WM Cong","year":"2001","unstructured":"Cong WM, Bakker A, Swalsky PA, et al. Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study. J Cancer Res Clin Oncol. 2001;127:187\u2013192.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1352_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1749-6632.2000.tb06705.x","volume":"910","author":"T Soussi","year":"2000","unstructured":"Soussi T. The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci. 2000;910:121\u2013137.","journal-title":"Ann N Y Acad Sci"},{"key":"1352_CR9","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.1998.16.9.3158","volume":"16","author":"DG Kirsch","year":"1998","unstructured":"Kirsch DG, Kastan MB. Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol. 1998;16:3158\u20133168.","journal-title":"J Clin Oncol"},{"key":"1352_CR10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1183\/09031936.01.00062201","volume":"18","author":"E Steels","year":"2001","unstructured":"Steels E, Paesmans M, Berghmans T, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18:705\u2013719.","journal-title":"Eur Respir J"},{"key":"1352_CR11","first-page":"927","volume":"47","author":"R Havlik","year":"2000","unstructured":"Havlik R, Sbis\u00e0 E, Tullo A, et al. Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology. 2000;47:927\u2013931.","journal-title":"Hepatogastroenterology"},{"key":"1352_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/ejso.1998.0645","volume":"25","author":"AM Rijken","year":"1999","unstructured":"Rijken AM, Offerhaus GJ, Polak MM, et al. p53 expression as a prognostic determinant in resected distal bile duct carcinoma. Eur J Surg Oncol. 1999;25:297\u2013301.","journal-title":"Eur J Surg Oncol"},{"key":"1352_CR13","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1245\/s10434-006-9260-0","volume":"14","author":"Q Cheng","year":"2007","unstructured":"Cheng Q, Luo X, Zhang B, et al. Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol. 2007;14:1212\u20131219.","journal-title":"Ann Surg Oncol"},{"key":"1352_CR14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/1097-0142(20010401)91:7<1332::AID-CNCR1136>3.0.CO;2-4","volume":"91","author":"P Argani","year":"2001","unstructured":"Argani P, Shaukat A, Kaushal M, et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer. 2001;91:1332\u20131341.","journal-title":"Cancer"},{"key":"1352_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<86::AID-CNCR10>3.0.CO;2-9","volume":"82","author":"T Suto","year":"1998","unstructured":"Suto T, Sugai T, Nakamura S, et al. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct. Cancer. 1998;82:86\u201395.","journal-title":"Cancer"},{"key":"1352_CR16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3349\/ymj.1996.37.2.112","volume":"37","author":"YC Lee","year":"1996","unstructured":"Lee YC, Song SY, Chung JB, et al. p53 protein expression in extrahepatic bile duct cancer. Yonsei Med J. 1996;37:112\u2013117.","journal-title":"Yonsei Med J"},{"key":"1352_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jcp.2004.018887","volume":"58","author":"D Santini","year":"2005","unstructured":"Santini D, Tonini G, Vecchio FM, et al. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma. J Clin Pathol. 2005;58:159\u2013165.","journal-title":"J Clin Pathol"},{"key":"1352_CR18","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MKB Parmar","year":"1998","unstructured":"Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815\u20132834.","journal-title":"Stat Med"},{"key":"1352_CR19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjc.6602358","volume":"92","author":"AJ Munro","year":"2005","unstructured":"Munro AJ, Lain S, Lane DP. P53 abnormalities and outcomes in colorectal cancer: a systematic review. Br J Cancer. 2005;92:434\u2013444.","journal-title":"Br J Cancer"},{"key":"1352_CR20","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/sj.bjc.6690628","volume":"80","author":"PD Pharoah","year":"1999","unstructured":"Pharoah PD, Day NE, Caldas C. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer. 1999;80:1968\u20131973.","journal-title":"Br J Cancer"},{"key":"1352_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3835(00)00381-5","volume":"153","author":"M Huncharek","year":"2000","unstructured":"Huncharek M, Kupelnick B, Geschwind JF, et al. Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies. Cancer Lett. 2000;153:219\u2013226.","journal-title":"Cancer Lett"},{"key":"1352_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16\u201331.","journal-title":"Trials"},{"key":"1352_CR23","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u2013748.","journal-title":"J Natl Cancer Inst"},{"key":"1352_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000227727","volume":"54","author":"T Suto","year":"1997","unstructured":"Suto T, Sugai T, Nakamura S, et al. Immunohistochemical detection of proliferating cell nuclear antigen and p53 expression in carcinoma of the extrahepatic bile duct. Oncology. 1997;54:407\u2013413.","journal-title":"Oncology"},{"key":"1352_CR25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.MP.0000036450.61830.8E","volume":"15","author":"MP Hoang","year":"2002","unstructured":"Hoang MP, Murakata LA, Katabi N, et al. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol. 2002;15:1251\u20131258.","journal-title":"Mod Pathol"},{"key":"1352_CR26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/1097-0142(20000801)89:3<508::AID-CNCR5>3.0.CO;2-D","volume":"89","author":"J Albores-Saavedra","year":"2000","unstructured":"Albores-Saavedra J, Murakata L, Krueger JE, et al. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer. 2000;89:508\u2013515.","journal-title":"Cancer"},{"key":"1352_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3835(00)00383-9","volume":"154","author":"X Li","year":"2000","unstructured":"Li X, Hui AM, Takayama T, et al. Altered p21WAF1\/CIP1 expression is associated with poor prognosis in extrahepatic bile duct carcinoma. Cancer Lett. 2000;154:85\u201391.","journal-title":"Cancer Lett"},{"key":"1352_CR28","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/modpathol.3880238","volume":"13","author":"M Takashima","year":"2000","unstructured":"Takashima M, Ueki T, Nagai E, et al. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol. 2000;13:1300\u20131307.","journal-title":"Mod Pathol"},{"key":"1352_CR29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s002689910011","volume":"24","author":"SH Park","year":"2000","unstructured":"Park SH, Kim YI, Park YH, et al. Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater. World J Surg. 2000;24:54\u201359.","journal-title":"World J Surg"},{"key":"1352_CR30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ejca.2007.01.004","volume":"43","author":"CD Mann","year":"2007","unstructured":"Mann CD, Neal CP, Garcea G, et al. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer. 2007;43:979\u2013992.","journal-title":"Eur J Cancer"},{"key":"1352_CR31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199205143262008","volume":"326","author":"AJ Levine","year":"1992","unstructured":"Levine AJ. The p53 tumor-suppressor gene. N Engl J Med. 1992;326:1350\u20131352.","journal-title":"N Engl J Med"},{"key":"1352_CR32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/bjc.1991.74","volume":"63","author":"N Scott","year":"1991","unstructured":"Scott N, Sagar P, Stewart J, et al. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer. 1991;63:317\u2013319.","journal-title":"Br J Cancer"},{"key":"1352_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.gastro.2005.10.014","volume":"130","author":"P Wong","year":"2006","unstructured":"Wong P, Verselis SJ, Garber JE, et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li\u2013Fraumeni syndrome. Gastroenterology. 2006;130:73\u201379.","journal-title":"Gastroenterology"},{"key":"1352_CR34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/humu.10189","volume":"21","author":"T Soussi","year":"2003","unstructured":"Soussi T, B\u00e9roud C. Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides. Hum Mutat. 2003;21:192\u2013200.","journal-title":"Hum Mutat"},{"key":"1352_CR35","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.onc.1210280","volume":"26","author":"T Soussi","year":"2007","unstructured":"Soussi T. p53 alterations in human cancer: more questions than answers. Oncogene. 2007;26:2145\u20132156.","journal-title":"Oncogene"},{"key":"1352_CR36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/jnci\/djk032","volume":"99","author":"PA Kyzas","year":"2007","unstructured":"Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007;99:236\u2013243.","journal-title":"J Natl Cancer Inst"},{"key":"1352_CR37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jnci\/dji184","volume":"97","author":"PA Kyzas","year":"2005","unstructured":"Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97:1043\u20131055.","journal-title":"J Natl Cancer Inst"},{"key":"1352_CR38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1200\/JCO.2005.04.6631","volume":"24","author":"WR Jarnagin","year":"2006","unstructured":"Jarnagin WR, Klimstra DS, Hezel M, et al. Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol. 2006;24:1152\u20131160.","journal-title":"J Clin Oncol"},{"key":"1352_CR39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.1639","volume":"97","author":"K Caca","year":"2002","unstructured":"Caca K, Feisthammel J, Klee K, et al. Inactivation of the INK4a\/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Int J Cancer. 2002;97:481\u2013488.","journal-title":"Int J Cancer"},{"key":"1352_CR40","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1478-3231.2005.01106.x","volume":"25","author":"SA Khan","year":"2005","unstructured":"Khan SA, Thomas HC, Toledano MB, et al. p53 Mutations in human cholangiocarcinoma: a review. Liver Int. 2005;25:704\u2013716.","journal-title":"Liver Int"},{"key":"1352_CR41","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.onc.1210302","volume":"26","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Achatz MI, Borresen-Dale AL, et al. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene. 2007;26:2157\u20132165.","journal-title":"Oncogene"},{"key":"1352_CR42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1470-2045(05)70315-6","volume":"6","author":"N Malats","year":"2005","unstructured":"Malats N, Bustos A, Nascimento CM, et al. P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol. 2005;6:678\u2013686.","journal-title":"Lancet Oncol"},{"key":"1352_CR43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrc1455","volume":"4","author":"AM Bode","year":"2004","unstructured":"Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4:793\u2013805.","journal-title":"Nat Rev Cancer"},{"key":"1352_CR44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00019606-200003000-00007","volume":"9","author":"G Della Torre","year":"2000","unstructured":"Della Torre G, Pasquini G, Pilotti S, et al. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas. Diagn Mol Pathol. 2000;9:41\u201346.","journal-title":"Diagn Mol Pathol"},{"key":"1352_CR45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2072","volume":"7","author":"T Stiewe","year":"2007","unstructured":"Stiewe T. The p53 family in differentiation and tumorigenesis. Nat Rev Cancer. 2007;7:165\u2013168.","journal-title":"Nat Rev Cancer"},{"key":"1352_CR46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.cdd.4401897","volume":"13","author":"AI Zaika","year":"2006","unstructured":"Zaika AI, El-Rifai W. The role of p53 protein family in gastrointestinal malignancies. Cell Death Differ. 2006;13:935\u2013940.","journal-title":"Cell Death Differ"},{"key":"1352_CR47","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1038\/sj.onc.1210337","volume":"26","author":"MP Deyoung","year":"2007","unstructured":"Deyoung MP, Ellisen LW. p63 and p73 in human cancer: defining the network. Oncogene. 2007;26:5169\u20135183.","journal-title":"Oncogene"},{"key":"1352_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10735-007-9084-7","volume":"38","author":"SM Hong","year":"2007","unstructured":"Hong SM, Cho H, Moskaluk CA, et al. p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. J Mol Histol. 2007;38:167\u2013175.","journal-title":"J Mol Histol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1352-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1352-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1352-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T19:41:54Z","timestamp":1559331714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1352-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,29]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1352-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,29]]}}}